Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

California

La Jolla California 92037-0845

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction or Gastrointestinal Stromal Tumor (GIST)

Oklahoma

Tulsa Oklahoma 74146

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Washington

MultiCare Health System
Tacoma Washington 98405

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach

Argentina

Buenos Aires 1025

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Rosario 2000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Viedma 8500

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Australia

Adelaide 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

France

Brest 29609

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Creteil 94010

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Lyon 69437

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Paris 75013

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Germany

Berlin 13125

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Hungary

Budapest 1125

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Kaposvar 7400

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Szolnok 5000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Korea, Republic of

Busan 612-896

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Daegu 702-210

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Goyang-si, Gyeonggi-do 410-769

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Jeollanam-do 519-763

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seongnam-si, Gyeonggi-do

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

View More ▼

Seoul 120-752

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 135-710

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 137-701

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 152-703

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 135-720

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Seoul 138-736

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Suwon 443-380

Patients are needed to participate in a clinical research study evaluating Paclitaxel for the treatment of Stage IV Gastric Cancer

Poland

Gdansk 80-219

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Lodz 90-242

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Poznan 61-485

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Warszawa 04-125

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Romania

Baia Mare 430031

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Cluj-Napoca 400058

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Craiova 200347

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Russian Federation

Arkhangelsk 163045

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Kursk 305035

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

St. Petersburg 194291

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Slovakia

Bratislava 833 10

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

Kosice 041-90

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma